1. Lane SS, Modi SS, Lehmann RP, Holland EJ. Nepafenac ophthalmic suspension 0.1% in the treatment of postoperative ocular inflammation associated with cataract surgery. J Cataract Refract Surg. 2007;33(1):53-58.
2. Lindstrom R, Kim T. Ocular permeation and inhibition of retinal inflammation by nepafenac. Curr Med Res Opin. 2006;22(11):209-215.